Walleye Trading
TNGX icon

Walleye Trading’s Tango Therapeutics TNGX Stock Holding History

Walleye Trading’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,381
Closed -$112K – 5404
2022
Q4 		$112K Buy
+15,381
New +$108K ﹤0.01% 3921
2021
Q4 		– Sell
-13,805
Closed -$178K – 5876
2021
Q3 		$178K Buy
+13,805
New +$165K ﹤0.01% 3986

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Walleye Trading's TNGX Position: Q1 2023 in Review

Walleye Trading sold out of Tango Therapeutics (TNGX) in Q1 2023, closing a stake of 15,381 shares — an estimated $112K sold.

Walleye Trading first reported a position in TNGX in Q3 2021 and held it in 2 quarters. The position peaked at $178K in Q3 2021. 92 funds tracked by Wall St. Rank hold TNGX as of Q1 2023.

  • Walleye Trading reported no remaining Tango Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Walleye Trading sold 15,381 Tango Therapeutics shares in Q1 2023, an estimated $112K.
  • Walleye Trading first reported a position in Tango Therapeutics in Q3 2021 and held it in 2 quarters.
  • Walleye Trading's Tango Therapeutics position peaked at $178K in Q3 2021.
  • 92 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.